Natural History of Pre-diabetic Autoimmunity (DAISY)
Natural History of Pre-diabetic Autoimmunity (DAISY)
批准号:
7260523
负责人:
MARIAN J REWERS
金额:
$84.03万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-11-01 至 2011-05-31
关键词:
AddressAgeAge-MonthsAllelesAppearanceAutoantibodiesAutoimmune DiseasesAutoimmunityBirthBirth OrderBlood ScreeningBlood specimenBreast FeedingC-PeptideCattleCellsCerealsChildChildhoodClinic VisitsCytomegalovirusData SetDay CareDevelopmentDiabetes MellitusDietDoctor of PhilosophyEnrollmentEnterovirusEnvironmentEnvironmental ExposureEnvironmental Risk FactorEpitopesEthnic OriginEventExposure toFamily history ofFecesFrequenciesGeneral PopulationGenesGeneticGenetic MarkersGenetic PolymorphismGenetic RiskGenotypeGlutenGoalsHLA-A AntigensHLA-A geneHLA-A2 AntigenHLA-DRB1*0401HaplotypesHerpesviridaeHerpesvirus 1HouseholdHuman Herpesvirus 2Human Herpesvirus 4ICA512 autoantibodyImmunizationIncidenceInfantInfectionInsulinInsulin-Dependent Diabetes MellitusIntakeIntercellular adhesion molecule 1Islets of LangerhansLaboratoriesLifeMapsMeatMilkNatural HistoryNested Case-Control StudyNewborn InfantNumbersPaperParentsParticipantPatientsPersonsPopulationPopulation ControlProductionProgress ReportsPublishingRaceRateRelative (related person)Relative RisksReportingResearch DesignResearch PersonnelResolutionRiskRisk FactorsRotavirusSamplingScreening procedureSiblingsSimplexvirusStratificationTestingTimeUmbilical Cord BloodVaccinationVaccinesViral AntibodiesVitamin D3 ReceptorVitaminsWomanbasecase controlcohortdiabetes riskdiabeticearly childhoodfollow-upfruits and vegetablesgene environment interactiongenetic risk factorhuman leukocyte antigen geneisletmenpet animalprobandprogramsprospectiveresponsetransmission processviral RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This project, called Diabetes AutoimmunityStudy in the Young (DAISY) began in July 1993 and allowed us to establish
two unique cohorts of very young children who are at up to 20-fold increased risk of type 1 diabetes: 1) a cohort of 693
siblings and offspring (current median age 4.5 years) of persons with type 1 diabetes and 1007 of their relatives; and 2) a
cohort of 1,069newborns (current median age 3.1 years) with type 1 diabetes-associated HLA-DR,DQ alleles, identified
through a cord blood screening of 21,713 general population children without a diabetic relative and 1,491 of their relatives.
To date, a short prospective follow-up of these cohorts has already provided new important information concerning the
natural history of b-cell autoimmunity and diabetes in early childhood. Based on our findings, we are proposing to follow
these cohorts through the period of the highest risk of b-cell autoimmunity and to address the following goals:
Specific Aims
1. To continue enrollment and follow-up, until the median age of 10yrs,of the existing cohorts of siblings/offspring and of
newborns at high and moderate genetic risk detected through general population HLA-DR,DQ screening to: a) former define
the incidence of b-cell autoimmunityby age,race/ethnicity, HLA-genotype, and family history of type 1 diabetes; b) formally
evaluate candidate autoimmunity/diabetes risk factors available for all participants, e.g., early childhood diet, reported
infections, and vaccination; and c) sustain this population laboratory for additional studies of type 1 diabetes and other
autoimmune diseases.
2. To continue current and initiate new case-control studies, nested in the cohorts, of selected environmental and genetic
risk factors for: a) b-cell autoimmunityand its persistence; and b) progression from b-cell autoimmunityto diabetes
3. Based on our findings, initiate intensive follow-up from birth of eighty highest risk children (HLA-DR3/4,DQB1 *0302
relatives) with monthly filter paper blood samples and weekly stool samples in addition to tri-monthly clinic visits.
4. To explore gene-environment interactions using combined approaches of case-control and case parent analyses.
Our study is filling important gaps in the understanding of the events leading to type 1 diabetes in early childhood by
providing the first unbiased population estimates of the incidence of b-cell autoimmunityand of the relative risks associated
with candidate environmental and genetic factors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Resource Core
-
批准号:10392978
-
项目类别:
-
资助金额:$14.44万
-
财政年份:2020
-
负责人:MARIAN J REWERS
-
依托单位:
Clinical Resource Core
-
批准号:10646146
-
项目类别:
-
资助金额:$14.23万
-
财政年份:2020
-
负责人:MARIAN J REWERS
-
依托单位:
Developing Pediatric Diabetes Investigators for the Future
-
批准号:9188204
-
项目类别:
-
资助金额:$39.51万
-
财政年份:2011
-
负责人:MARIAN J REWERS
-
依托单位:
Integrated Cardio-Renal Risk Prediction Models in Type 1 Diabetes
-
批准号:7829755
-
项目类别:
-
资助金额:$49.69万
-
财政年份:2010
-
负责人:MARIAN J REWERS
-
依托单位:
CORE--CLINICAL INVESTIGATION AND INFORMATICS
-
批准号:7858104
-
项目类别:
-
资助金额:$20.61万
-
财政年份:2009
-
负责人:MARIAN J REWERS
-
依托单位:
CORONARY ARTERY CALCIFICATION IN TYPE I DIABETES
-
批准号:7719420
-
项目类别:
-
资助金额:$2.06万
-
财政年份:2008
-
负责人:MARIAN J REWERS
-
依托单位:
DETERMINANTS OF INSULIN SENSITIVITY IN TYPE 1 DIABETES
-
批准号:7719498
-
项目类别:
-
资助金额:$0.62万
-
财政年份:2008
-
负责人:MARIAN J REWERS
-
依托单位:
DETERMINANTS OF INSULIN SENSITIVITY IN TYPE 1 DIABETES
-
批准号:7604448
-
项目类别:
-
资助金额:$5.25万
-
财政年份:2007
-
负责人:MARIAN J REWERS
-
依托单位:
CORONARY ARTERY CALCIFICATION IN TYPE I DIABETES
-
批准号:7604370
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2007
-
负责人:MARIAN J REWERS
-
依托单位:
DETERMINANTS OF INSULIN SENSITIVITY IN TYPE 1 DIABETES
-
批准号:7377862
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2006
-
负责人:MARIAN J REWERS
-
依托单位:
The 10th Symposium of the International Diabetes Epidemiology Group - a Satellite
-
批准号:7282213
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2006
-
负责人:MARIAN J REWERS
-
依托单位:
The 10th Symposium of the International Diabetes Epidemiology Group
-
批准号:7225098
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2006
-
负责人:MARIAN J REWERS
-
依托单位:
CORE--CLINICAL INVESTIGATION AND INFORMATICS
-
批准号:7311613
-
项目类别:
-
资助金额:$20.66万
-
财政年份:2006
-
负责人:MARIAN J REWERS
-
依托单位:
CORONARY ARTERY CALCIFICATION IN TYPE I DIABETES
-
批准号:7377764
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2006
-
负责人:MARIAN J REWERS
-
依托单位:
CORONARY ARTERY CALCIFICATION IN TYPE I DIABETES
-
批准号:7200524
-
项目类别:
-
资助金额:$4.6万
-
财政年份:2005
-
负责人:MARIAN J REWERS
-
依托单位:
Determinants of Accelerated CVD in Type 1 Diabetes
-
批准号:6878873
-
项目类别:
-
资助金额:$60.84万
-
财政年份:2004
-
负责人:MARIAN J REWERS
-
依托单位:
Coronary Artery Calcification in Type I Diabetes
-
批准号:6982138
-
项目类别:
-
资助金额:$26.42万
-
财政年份:2004
-
负责人:MARIAN J REWERS
-
依托单位:
Determinants of Accelerated CVD in Type 1 Diabetes
-
批准号:7122062
-
项目类别:
-
资助金额:$55.76万
-
财政年份:2004
-
负责人:MARIAN J REWERS
-
依托单位:
Genetic and Environmental Causes of Celiac Disease
-
批准号:7040986
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2004
-
负责人:MARIAN J REWERS
-
依托单位:
Determinants of Accelerated CVD in Type 1 Diabetes
-
批准号:6950008
-
项目类别:
-
资助金额:$61.54万
-
财政年份:2004
-
负责人:MARIAN J REWERS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: